Epinephrine 1.82 Mg/Ml, Solution for Injection Tender - 151281915

Procurement Summary

Country: Ukraine

Summary: Epinephrine 1.82 Mg/Ml, Solution for Injection, Ampoule; Metamizole Sodium, Solution for Injection, 500 Mg/Ml, 2 Ml; Povidone-Iodine, Solution for External Use, 10%, 50 Ml Each; Dexamethasone, Solution for Other...

Deadline: 23 Oct 2026

Posting Date: 22 Oct 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 151281915

Document Ref. No.: UA-2026-10-20-008845-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 9971.96

CPV Classification

33600000 - Pharmaceutical products
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33660000 - Medicinal products for the nervous system and sensory organs
33630000 - Medicinal products for dermatology and the musculo-skeletal system
33640000 - Medicinal products for the genitourinary system and hormones

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Epinephrine 1.82 mg/ml, solution for injection, ampoule; Metamizole sodium, solution for injection, 500 mg/ml, 2 ml; Povidone-iodine, solution for external use, 10%, 50 ml each; Dexamethasone, solution for injection 4mg/ml; Diclofenac solution for injection 25 mg/ml; Diphenhydramine, solution for injection, 10 mg/ml, 1 ml each; Drotaverin solution for injections 20 mg/ml, 2 ml in an ampoule; Ibuprofen tablets/capsules of 200 mg; Captopril, tablets, 25 mg each; Loperamide tablets/capsules of 2 mg each; Loratadine 10 mg tablets; Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each; Metoclopramide, solution for injection, 5 mg/ml, 2 ml each; Metoclopramide, tablets, 10 mg; Sodium chloride, solution for injection, 9 mg/ml, 5 ml each; Sodium chloride, solution for infusions, 9 mg/ml 200 ml; Pancreatin, Lipolytic units: 8000; Dexpanthenol foam for the skin 50 mg/g per 116 g; Salicylic acid, dermal solution (for external use), alcohol, 1%, 40 ml each; Furosemide, solution for injection, 10 mg/ml, 2 ml each; Chlorhexidine, solution for external use 0.05% per 100 ml; Prednisone, solution for injection, 30 mg/ml, 1 ml each; Acetylsalicylic acid tablets of 500 mg; Activated charcoal tablets/capsules of 250 mg each; Paracetamol tablets/capsules 500 mg
Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Classification according to ATX: D08AC02, INN: Chlorhexidine, Release form: Solution for external use, Dose of active substance: 0.05%, Volume: 100 ml, Type of packaging: Bottle; Acetylsalicylic acid tablets of 500 mg Acetylsalicylic acid, N02BA01, B01AC06, Tablets, Enteric-coated tablets, Effervescent tablets, 500 mg, Contour blister packaging, Strip, Blister, Vial; Paracetamol tablets/capsules 500 mg NameClassifier and its corresponding codeQuantity/Measurement unitsPlace of deliveryDate of deliveryName
DK 021:2015: 33600000-6 — Pharmaceutical products Classification according to ATX: D08AC02, INN: Chlorhexidine, Release form: Solution for external use, Dose of the active substance: 0.05%, Volume: 100 ml, Packaging type: Vial; Acetylsalicylic acid 500 mg acetylsalicylic acid, N02BA01, B01AC06, Tablets, Enteric-coated tablets, Effervescent tablets, 500 mg, Contour blister packaging, Strip, Blister, Vial; Paracetamol tablets/ capsules 500 mg Name Classifier and its corresponding code Quantity/Units measurementPlace of deliveryDate of deliveryName

Documents

 Tender Notice